Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

High-frequency positive-pressure ventilation in neonates.

F G Eyal, I D Arad, K Godder

    Critical Care Medicine
    |September 1, 1984
    PubMed
    Summary

    High-frequency positive-pressure ventilation (HFPPV) improved oxygenation and reduced carbon dioxide in newborns with severe respiratory failure. This advanced ventilation method demonstrated significant survival benefits for critically ill neonates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Cross-reactive anti-prophage antibodies and bacterial heteroresistance implicated in phage therapeutic failure.

    Nature medicine·2026
    Same author

    Histopathology of the heart in tetanus.

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
    Same author

    Angiosarcoma of the heart predominantly involving the pericardium: A clinicopathologic study with electron-microscopic and immunohistochemical correlation.

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
    Same author

    Left ventricular rupture through an area of fatty infiltration: Case report and review of the literature.

    Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2015
    Same author

    The effect of level of crude protein and available lysine on finishing pig performance, nitrogen balance and nutrient digestibility.

    Asian-Australasian journal of animal sciences·2014
    Same author

    Dectin-2 sensing of house dust mite is critical for the initiation of airway inflammation.

    Mucosal immunology·2013

    Area of Science:

    • Neonatal Medicine
    • Pediatric Respiratory Care
    • Critical Care

    Background:

    • Severe respiratory failure in newborns often necessitates advanced ventilatory support.
    • Conventional mechanical ventilation may be insufficient for certain critically ill neonates.
    • Exploring alternative ventilation strategies is crucial for improving outcomes in neonatal respiratory distress.

    Purpose of the Study:

    • To evaluate the efficacy and safety of high-frequency positive-pressure ventilation (HFPPV) in neonates with severe respiratory failure.
    • To compare HFPPV with conventional mechanical ventilation in terms of gas exchange and clinical outcomes.
    • To assess the potential benefits of HFPPV for neonates refractory to standard therapies.

    Main Methods:

    • Twenty-five newborn infants with severe respiratory failure were transitioned to HFPPV.

    Related Experiment Videos

  • HFPPV was delivered at high rates (90-180 cycles/min) with small tidal volumes (≤3 ml/kg).
  • Parameters included a short inspiratory time (0.1 sec) and positive end-expiratory pressure (PEEP) of 3-17 cm H2O.
  • Main Results:

    • HFPPV rapidly improved arterial oxygen (PaO2) and reduced carbon dioxide (PaCO2) levels within 1 hour.
    • Fraction of inspired oxygen (FiO2) requirements decreased significantly after 14 hours of HFPPV.
    • Complications like pneumothorax (2 infants) and bronchopulmonary dysplasia (1 infant) were infrequent despite high PEEP.

    Conclusions:

    • HFPPV is an effective ventilatory strategy for neonates with severe respiratory failure unresponsive to conventional methods.
    • The technique led to improved gas exchange and a high survival rate (72%) without respiratory failure as a cause of death.
    • HFPPV offers a potentially beneficial therapeutic option for managing critical neonatal respiratory conditions.